Test ID: C2729
Breast Carcinoma-Associated Antigen (CA 27.29), Serum
Secondary ID 
A test code used for billing and in test definitions created prior to November 2011
81413
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Yes
Useful For Suggests clinical disorders or settings where the test may be helpful
The FDA has approved CA 27.29 for serial testing in women with prior stage II or III breast cancer who are clinically free of disease.
Predicting early recurrence of disease in women with treated carcinoma of the breast
As an indication that additional tests or procedures should be performed to confirm recurrence of breast cancer
Method Name A short description of the method used to perform the test
Chemiluminometric Immunoassay
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Breast Carcinoma Assoc Ag(CA 27.29)
Aliases Lists additional common names for a test, as an aid in searching
Biomira Truquant BR
Breast Cancer Tumor Markers
Breast Carcinoma
Cancer Antigen 27.29 (CA 27.29)
MAM 6
Milk Mucin
Breast Cancer Tumor Markers
Breast Carcinoma
Cancer Antigen 27.29 (CA 27.29)
MAM 6
Milk Mucin
External
link
PDF
document
Excel
document
Word
document